Quality-of-Life Outcomes Among Patients Achieving High-Threshold Facial or Total Body Repigmentation With Ruxolitinib Cream in Nonsegmental Vitiligo. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s753. https://doi.org/10.25251/r559dc08